| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/12/2013 | CN103142512A High-quality composition containing oxaliplatin and preparation method of composition |
| 06/12/2013 | CN103142511A High-purity and high-stability composition containing oxaliplatin and preparation method of composition |
| 06/12/2013 | CN103142509A Bortezomib pharmaceutic composition for injection |
| 06/12/2013 | CN103142500A Sustained-release particle of etoposide |
| 06/12/2013 | CN103142499A 一种依托泊苷颗粒 One kind of particle etoposide |
| 06/12/2013 | CN103142497A Enteric granule of etoposide |
| 06/12/2013 | CN103142485A Etoposide dry suspension |
| 06/12/2013 | CN103142482A Preparation method for nanoparticle pharmaceutical composition, and nanoparticle pharmaceutical composition |
| 06/12/2013 | CN103142481A Drug-loaded liposome overcoming tumor drug resistance, preparation method and application thereof |
| 06/12/2013 | CN103142469A Application of using amphiphilic N-long-chain alkyl-N-arginine chitosan as solubilizing and absorption prompting carrier of gambogic acid |
| 06/12/2013 | CN103141853A Theaflavin health-care food or medicament and preparation method thereof |
| 06/12/2013 | CN102846667B Preparation method for nanometer Periplaneta americana through low temperature drying |
| 06/12/2013 | CN102631685B Coprecipitation method for preparing methotrexate/ layered double hydroxides nanocomposite material |
| 06/12/2013 | CN102600228B Method for preparing gypenoside in gypenoside grains |
| 06/12/2013 | CN102580102B Polyurethane drug release controlling body with thermoswitch and preparation method thereof |
| 06/12/2013 | CN102579503B Method for separating skin of eupolyphaga egg clamp from egg inside eupolyphaga egg clamp |
| 06/12/2013 | CN102579428B Application of tetranor-diterpene dilactone derivatives in preparing anticancer drug |
| 06/12/2013 | CN102499905B Controllable photoresponse type hydrophobic medicament carrier hydrogel and preparation method thereof |
| 06/12/2013 | CN102429932B Method for extracting lucid ganoderma essence |
| 06/12/2013 | CN102406610B Particle dosing system with long circulation performance and preparation method thereof |
| 06/12/2013 | CN102399820B Small interfering RNA directed at HPV16 E7 gene and its application |
| 06/12/2013 | CN102397547B Anti-cancer pharmaceutical composition |
| 06/12/2013 | CN102372772B Ruditapes philippin RpTNF gene recombinant protein, its preparation and application |
| 06/12/2013 | CN102357211B Traditional Chinese medicine composition for curing cancers |
| 06/12/2013 | CN102335429B Tumor inhibiting medicine composition and purpose thereof |
| 06/12/2013 | CN102335325B Method for processing fritillary decoction pieces |
| 06/12/2013 | CN102335201B Extract method of asteroid saponins |
| 06/12/2013 | CN102319392B Traditional Chinese medicine pill for treating uterine fibroids and preparation method thereof |
| 06/12/2013 | CN102309683B Application of traditional Chinese medicinal composition in preparing medicines for treating hysteromyoma |
| 06/12/2013 | CN102309539B Spina gleditsiae extract hydrogel patch and preparation method thereof |
| 06/12/2013 | CN102276581B N-substituted tetrahydropyridine bound indole compound as well as preparation method and application thereof |
| 06/12/2013 | CN102267983B Sym-triazine derivative compounds containing sym-tetrazine rings and preparation method thereof |
| 06/12/2013 | CN102266566B Magnetic compound, and preparation method and purpose thereof |
| 06/12/2013 | CN102250852B Clone and expression of bovine recombinant alpha-1,3-galactoside transferase (GT) |
| 06/12/2013 | CN102241726B Glycyrrhetinic acid derivative and application thereof as antitumor medicament |
| 06/12/2013 | CN102234283B 4'-demethyl epipodophyllotoxin derivatives, and synthesis method and application thereof |
| 06/12/2013 | CN102229595B Sesquiterpenoids in Cordyceps Ophioglossoides and use thereof |
| 06/12/2013 | CN102228442B Star-like macromolecule nanometer microsphere and preparation method and application thereof |
| 06/12/2013 | CN102225059B Application of mannitol in preparing antitumor medicines |
| 06/12/2013 | CN102210862B Livin-based immune-stimulating complex, preparation method thereof and application thereof |
| 06/12/2013 | CN102209539B P70 S6 kinase inhibitor and MTOR inhibitor combination therapy |
| 06/12/2013 | CN102209538B P70 S6 kinase inhibitor and EGFR inhibitor combination therapy |
| 06/12/2013 | CN102140465B Human miR-1249 antisense nucleic acid and application thereof |
| 06/12/2013 | CN102140462B Human miR-1260 antisense nucleic acid and application thereof |
| 06/12/2013 | CN102133333B Quality control method for shenmai injection mass spectrum finger prints |
| 06/12/2013 | CN102125696B Oligomeric ribonucleic acid composite for inhibiting tumor growth and angiogenesis and application thereof |
| 06/12/2013 | CN102125547B Pharmaceutical composition containing gambogic acid medicament and preparation method thereof |
| 06/12/2013 | CN102106944B Application of palmate pinellia tuber protein in treatment of cervical carcinoma and preparation thereof |
| 06/12/2013 | CN102101874B Di(cyclopentadienyl)iron pyrazol copper and silver complexes and use thereof |
| 06/12/2013 | CN102093431B Organotin-oxygen cluster containing ferrocene pyrazole and application of cluster |
| 06/12/2013 | CN102093353B 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
| 06/12/2013 | CN102093339B Preparation method and application of pyrimidine derivatives |
| 06/12/2013 | CN102090622B Sparassia crispa(Wulf.)Fr. solution preparation method |
| 06/12/2013 | CN102088969B Combination of spacitabine (CNDAC) and DNA methyltransferase inhibitors such as decitabine and procaine |
| 06/12/2013 | CN102031255B Antisense nucleic acid of human miR-223 and applications of antisense nucleic acid |
| 06/12/2013 | CN102002071B Ferrocenedicarboxylic acid trialkyl tin chloride coordination compound as well as preparation method and application thereof |
| 06/12/2013 | CN101970424B Indolyl- pyridone derivatives having checkpoint kinase 1 inhibitory activity |
| 06/12/2013 | CN101932565B Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor |
| 06/12/2013 | CN101914135B Broad-spectrum chemokine receptor antagonistic polypeptide and application thereof |
| 06/12/2013 | CN101906054B N-(3,4-dyhydroxy benzoyl)-3,4-dyhydroxy benzamide and preparation method and application thereof |
| 06/12/2013 | CN101863766B Beta-hydroxyisovalerylshikonin derivative and preparation method thereof |
| 06/12/2013 | CN101743005B Potentiation of cancer chemotherapy by 7-(2,5-dihydro-4-imidazo [1,2-a]pyrine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyd-pyrrolo[3,2,1-jk][1,4]benzodiazepine |
| 06/12/2013 | CN101688229B Treatment method using EGFR antibodies and SRC inhibitors and related formulations |
| 06/12/2013 | CN101674834B Inhibitors of bruton's tyrosine kinase |
| 06/12/2013 | CN101668736B Amidation process for the preparation of cathepsin k inhibitors |
| 06/12/2013 | CN101657453B Purines as PKC-theta inhibitors |
| 06/12/2013 | CN101605794B Aza-benzofuranyl compounds and methods of use |
| 06/12/2013 | CN101600683B Therapeutic compounds |
| 06/12/2013 | CN101547705B Compositions and methods for treating a neoplasm |
| 06/12/2013 | CN101481325B Basic amino acid metalloproteinase inhibitor and use thereof |
| 06/12/2013 | CN101479274B Pharmaceutical compounds |
| 06/12/2013 | CN101466737B Targeted binding agents directed to uPAR and uses thereof |
| 06/12/2013 | CN101448858B Combinatorial therapy involving alpha5beta1 antagonists |
| 06/12/2013 | CN101437852B Anti-TAT226 antibodies and immunoconjugates |
| 06/12/2013 | CN101432307B Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 06/12/2013 | CN101307106B Endothelial cell proliferation inhibitor and method of use |
| 06/12/2013 | CN101287492B Anti-glypican-3 antibody |
| 06/12/2013 | CN101280025B Antitumaous echinus shell polysaccharide and preparation thereof |
| 06/12/2013 | CN101198623B Methods and compositions for modulating and detecting WISP activity |
| 06/11/2013 | US8461330 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 06/11/2013 | US8461321 Nucleic acids encoding a deletion variant of uPAR |
| 06/11/2013 | US8461309 Inhibitor protein of the wnt signal pathway |
| 06/11/2013 | US8461212 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/11/2013 | US8461199 Transition metal complexes of a bis[thio-hydrazide amide] compound |
| 06/11/2013 | US8461175 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof |
| 06/11/2013 | US8461150 Chalcone linked pyrrolo[2,1-c][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof |
| 06/11/2013 | US8461139 Oral suspension of prednisolone acetate |
| 06/11/2013 | US8461136 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 06/11/2013 | US8461117 Chemical linkers and cleavable substrates and conjugates thereof |
| 06/11/2013 | US8461109 Method of enhancing the acceptance and/or healing of a skin graft |
| 06/11/2013 | US8460675 Viral chemokine-antigen fusion proteins |
| 06/11/2013 | US8460661 Methods of using antibodies that bind the glutamate ligand binding region of Notch1 |
| 06/11/2013 | CA2722102C Phenylpropionic acid derivative and use thereof |
| 06/11/2013 | CA2665949C Vinca alkaloid antimitotic halogenated derivatives |
| 06/11/2013 | CA2662737C The preparation and the use of ethoxy combretastatins and their prodrugs |
| 06/11/2013 | CA2605617C Photodynamic therapy using chemiluminescence and a ligand-photosensitiser conjugate |
| 06/11/2013 | CA2581516C Quinazoline derivatives |
| 06/11/2013 | CA2572218C Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents |
| 06/11/2013 | CA2562617C (poly)aminoalkylaminoacetamide derivatives of epipodophyllotoxin, their process of preparation and their applications in therapeutics as anticancer agents |
| 06/11/2013 | CA2546101C N-acylsulfonamide apoptosis promoters |